These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7525868)

  • 61. Sequential changes of dopaminergic receptors in the rat brain after 6-hydroxydopamine lesions of the medial forebrain bundle.
    Araki T; Tanji H; Kato H; Itoyama Y
    J Neurol Sci; 1998 Oct; 160(2):121-7. PubMed ID: 9849794
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment.
    Joyce JN
    Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
    Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons.
    Dawson VL; Dawson TM; Wamsley JK
    Brain Res Bull; 1990 Dec; 25(6):903-12. PubMed ID: 2149667
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
    Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
    Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ontogeny of D1A and D2 dopamine receptor subtypes in rat brain using in situ hybridization and receptor binding.
    Schambra UB; Duncan GE; Breese GR; Fornaretto MG; Caron MG; Fremeau RT
    Neuroscience; 1994 Sep; 62(1):65-85. PubMed ID: 7816213
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study.
    Rao PA; Molinoff PB; Joyce JN
    Brain Res Dev Brain Res; 1991 Jun; 60(2):161-77. PubMed ID: 1832594
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Compartment-specific changes in the density of choline and dopamine uptake sites and muscarinic and dopaminergic receptors during the development of the baboon striatum: a quantitative receptor autoradiographic study.
    Lowenstein PR; Slesinger PA; Singer HS; Walker LC; Casanova MF; Raskin LS; Price DL; Coyle JT
    J Comp Neurol; 1989 Oct; 288(3):428-46. PubMed ID: 2794143
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Progressive supranuclear paralysis. Quantification of dopamine D2 receptors using radionuclide tomography].
    Tranquart F; Le Bras FH; de Toffol B; Autret A; Guilloteau D; Baulieu JL
    Presse Med; 1994 Sep; 23(28):1299-300. PubMed ID: 7984527
    [TBL] [Abstract][Full Text] [Related]  

  • 70. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
    Gerfen CR; Engber TM; Mahan LC; Susel Z; Chase TN; Monsma FJ; Sibley DR
    Science; 1990 Dec; 250(4986):1429-32. PubMed ID: 2147780
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies.
    Levey AI; Hersch SM; Rye DB; Sunahara RK; Niznik HB; Kitt CA; Price DL; Maggio R; Brann MR; Ciliax BJ
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8861-5. PubMed ID: 8415621
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Autoradiographic localization of D1 and D2 dopamine receptors in the human brain.
    De Keyser J; Claeys A; De Backer JP; Ebinger G; Roels F; Vauquelin G
    Neurosci Lett; 1988 Aug; 91(2):142-7. PubMed ID: 2972942
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dopamine-opiate interaction in the regulation of neostriatal and pallidal neuronal activity as assessed by opioid precursor peptides and glutamate decarboxylase messenger RNA expression.
    Mavridis M; Besson MJ
    Neuroscience; 1999; 92(3):945-66. PubMed ID: 10426535
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors.
    Dubois A; Savasta M; Curet O; Scatton B
    Neuroscience; 1986 Sep; 19(1):125-37. PubMed ID: 2946980
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
    Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
    Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [3H]SCH 23390 binding to D1 dopamine receptors in the basal ganglia of the cat and primate: delineation of striosomal compartments and pallidal and nigral subdivisions.
    Besson MJ; Graybiel AM; Nastuk MA
    Neuroscience; 1988 Jul; 26(1):101-19. PubMed ID: 2901690
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
    Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
    Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Neurochemistry of Parkinson's disease and parkinsonism plus].
    Pascual J; Misiego M
    Rev Neurol; 1997 Aug; 25 Suppl 2():S141-6. PubMed ID: 9280680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.